Emami

₹609.2 35.9 | 6.3%

WEBSITE BSE:531162 NSE : EMAMI LTD. 09 Jul, 15:59

Market Cap ₹26589 Cr.

Stock P/E 36.7

P/B 9.9

Current Price ₹609.2

Book Value ₹ 61.7

Face Value 1

52W High ₹859.2

Dividend Yield 1.64%

52W Low ₹ 509.3

Edit Ratio

Emami Research see more...

Overview Inc. Year: 1995Industry: Household & Personal Products

Emami Ltd is a FMCG company. The Company is engaged in production and advertising personal care and healthcare merchandise. The Company's operating segments are Home Care and Personal. Its portfolio of household brand names which includes Zandu Balm, Navratna, Kesh King, Zandu Pancharishta, Boro Plus, Navratna, Fair and Handsome, fast relief, 7oils in one, Diamond shine, Emami golden beauty, Emami naturally fair, Mentho Plus Balm, Emami Emasol, Creme21 and others. It also offers BoroPlus Hygiene variety, EMASOL Home Hygiene, BoroPlus Organic Aloe Vera Gel, with numerous healthcare products beneath Zandu.

Emami Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Emami Quarterly Results

#(Fig in Cr.)	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Net Sales	983	836	826	865	996	891	906	891	1049	963
Other Income	7	14	8	11	17	11	10	22	15	21
Total Income	990	850	834	876	1013	902	917	912	1064	984
Total Expenditure	688	636	636	631	681	680	690	640	711	744
Operating Profit	301	214	198	245	332	222	227	272	354	241
Interest	2	1	2	2	3	3	2	2	2	3
Depreciation	47	64	46	46	46	48	44	45	46	44
Exceptional Income / Expenses	0	0	0	0	-6	0	0	0	0	0
Profit Before Tax	252	148	150	196	277	171	180	225	306	194
Provision for Tax	19	6	13	16	15	22	28	9	22	32
Profit After Tax	234	142	137	181	262	148	153	216	283	163
Adjustments	4	2	0	-2	-3	1	-0	-3	-4	-1
Profit After Adjustments	237	144	138	179	258	149	153	213	279	162
Adjusted Earnings Per Share	5.4	3.3	3.1	4.1	5.9	3.4	3.5	4.9	6.4	3.7

Emami Profit & Loss

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Net Sales	1821	2217	2358	2488	2531	2695	2655	2881	3187	3406	3578	3809
Other Income	73	182	109	89	96	35	57	70	95	69	47	68
Total Income	1894	2400	2468	2577	2627	2730	2712	2951	3282	3475	3625	3877
Total Expenditure	1387	1768	1736	1787	1888	1967	1964	1997	2235	2543	2629	2785
Operating Profit	507	632	732	790	739	762	748	953	1048	932	996	1094
Interest	5	5	54	58	34	21	21	13	5	7	10	9
Depreciation	35	34	255	309	311	325	336	367	335	247	186	179
Exceptional Income / Expenses	-9	0	0	0	0	-10	-11	0	-5	0	-6	0
Profit Before Tax	457	592	423	424	393	403	374	569	688	670	791	905
Provision for Tax	55	107	60	84	86	101	71	114	-149	42	67	91
Profit After Tax	402	485	363	340	306	303	302	455	837	627	724	815
Adjustments	0	0	0	0	1	1	1	-0	2	12	-1	-8
Profit After Adjustments	402	486	364	340	307	303	303	455	839	640	724	807
Adjusted Earnings Per Share	8.9	10.7	8	7.5	6.8	6.7	6.7	10.2	19	14.5	16.6	18.5

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	5%	7%	6%	7%
Operating Profit CAGR	7%	1%	6%	7%
PAT CAGR	15%	17%	19%	6%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	-22%	9%	21%	0%
ROE Average	30%	34%	29%	28%
ROCE Average	33%	32%	29%	30%

Emami Balance Sheet

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Shareholder's Funds	932	1231	1612	1755	2014	2076	1824	1763	2077	2303	2447
Minority's Interest	0	5	4	1	1	-0	-1	-1	-2	10	11
Borrowings	17	2	300	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	34	53	42	65	70	63	64	58	-216	-290	-375
Total Current Liabilities	319	387	735	782	714	680	792	700	916	724	759
Total Liabilities	1302	1676	2692	2603	2798	2819	2678	2520	2774	2746	2842
Fixed Assets	396	453	1918	1940	1746	1625	1405	1079	1290	1192	1062
Other Non-Current Assets	61	80	269	222	351	344	240	314	411	267	362
Total Current Assets	846	1143	505	441	701	849	1033	1127	1073	1287	1418
Total Assets	1302	1676	2692	2603	2798	2819	2678	2520	2774	2746	2842

Emami Cash Flow

#(Fig in Cr.)	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Opening Cash & Cash Equivalents	281	268	350	101	28	16	116	11	20	28	47
Cash Flow from Operating Activities	428	534	562	730	588	554	531	922	644	749	779
Cash Flow from Investing Activities	-142	-234	-1306	-297	-279	-23	-228	-227	-235	-113	-205
Cash Flow from Financing Activities	-301	-215	502	-496	-324	-428	-405	-688	-402	-608	-563
Net Cash Inflow / Outflow	-15	85	-243	-64	-15	103	-102	6	7	28	11
Closing Cash & Cash Equivalent	268	350	101	28	16	116	11	20	28	47	53

Emami Ratios

#	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Earnings Per Share (Rs)	8.87	10.7	8.01	7.5	6.77	6.68	6.68	10.23	19.02	14.5	16.58
CEPS(Rs)	9.64	11.45	13.61	14.29	13.6	13.83	14.09	18.48	26.55	19.83	20.85
DPS(Rs)	7	7	7	7	7	4	4	8	8	8	8
Book NAV/Share(Rs)	20.53	27.11	35.5	38.66	44.36	45.73	40.24	39.65	47.07	52.2	56.05
Core EBITDA Margin(%)	23.38	19.92	25.97	27.74	25.3	26.99	26.01	30.66	29.88	25.33	26.54
EBIT Margin(%)	24.95	26.48	19.89	19.05	16.8	15.77	14.86	20.21	21.75	19.88	22.38
Pre Tax Margin(%)	24.66	26.25	17.63	16.76	15.45	14.97	14.07	19.75	21.59	19.66	22.1
PAT Margin (%)	21.71	21.51	15.14	13.45	12.05	11.23	11.39	15.79	26.25	18.42	20.24
Cash Profit Margin (%)	23.61	23.03	25.78	25.66	24.29	23.3	24.05	28.52	36.75	25.68	25.43
ROA(%)	30.23	32.6	16.62	12.84	11.34	10.77	11	17.49	31.61	22.73	25.92
ROE(%)	47.08	44.89	25.55	20.2	16.26	14.79	15.5	25.36	43.58	28.65	30.49
ROCE(%)	49.68	53.44	26.87	21.36	18.69	18.77	18.7	29.94	33.04	28.7	32.76
Receivable days	18.85	14.64	17.71	16.45	18.17	25.21	36.05	34.2	31.65	39.41	46.35
Inventory Days	25.12	21.66	21.1	23.8	26.8	28.15	32.06	34.54	37.68	36.74	33.23
Payable days	65.72	78.67	99.31	100	96.16	105.46	128.28	132.6	129.16	123.94	135.51
PER(x)	24.54	46.99	58.11	70.33	78.92	59.88	25.43	47.67	23.55	24.72	25.88
Price/Book(x)	10.59	18.54	13.11	13.65	12.04	8.75	4.22	12.3	9.51	6.87	7.65
Dividend Yield(%)	1.61	0.7	0.75	0.66	0.66	1	2.35	1.64	1.79	2.23	1.87
EV/Net Sales(x)	5.3	10.15	9.2	9.79	9.68	6.7	2.94	7.43	6.24	4.61	5.19
EV/Core EBITDA(x)	19.04	35.61	29.64	30.83	33.14	23.7	10.43	22.46	19	16.85	18.65
Net Sales Growth(%)	7.16	21.78	6.36	5.5	1.7	6.48	-1.48	8.5	10.65	6.86	5.06
EBIT Growth(%)	23.25	29.2	-20.21	1.01	-11.37	-0.48	-7.12	47.55	19.05	-2.33	18.3
PAT Growth(%)	27.88	20.63	-25.21	-6.35	-9.91	-1.23	-0.08	50.41	84	-25.01	15.42
EPS Growth(%)	27.87	20.66	-25.14	-6.36	-9.78	-1.27	0.06	53.03	85.92	-23.77	14.33
Debt/Equity(x)	0.04	0.03	0.42	0.27	0.16	0.05	0.12	0.05	0.13	0.03	0.03
Current Ratio(x)	2.65	2.96	0.69	0.56	0.98	1.25	1.3	1.61	1.17	1.78	1.87
Quick Ratio(x)	2.21	2.63	0.48	0.33	0.71	0.92	1	1.18	0.78	1.32	1.44
Interest Cover(x)	85.93	116.24	8.82	8.3	12.44	19.85	18.78	43.87	136.62	91.58	80.26
Total Debt/Mcap(x)	0	0	0.03	0.02	0.01	0.01	0.03	0	0.01	0	0

Emami Shareholding Pattern

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	54.27	54.27	54.52	54.84	54.84	54.84	54.84	54.84	54.84	54.84
FII	11.15	11.01	11.45	11.91	12.86	13.46	14.02	14.38	14.11	12.11
DII	27.02	26.92	26.23	25.21	23.95	22.07	21.61	21.5	21.7	23.67
Public	7.56	7.8	7.8	8.03	8.34	9.63	9.52	9.27	9.35	9.38
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Promoter	23.94	23.94	23.94	23.94	23.94	23.94	23.94	23.94	23.94	23.94
FII	4.92	4.86	5.03	5.2	5.61	5.88	6.12	6.28	6.16	5.29
DII	11.92	11.87	11.52	11.01	10.46	9.63	9.43	9.39	9.47	10.33
Public	3.34	3.44	3.42	3.51	3.64	4.2	4.16	4.05	4.08	4.09
Others	0	0	0	0	0	0	0	0	0	0
Total	44.12	44.12	43.91	43.65	43.65	43.65	43.65	43.65	43.65	43.65

Pros

Company has a good return on equity (ROE) track record: 3 Years ROE 34%
Company is almost debt free.

Cons

Debtor days have increased from 123.94 to 135.51days.
Stock is trading at 9.9 times its book value.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.